Literature DB >> 23232632

Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy.

Kevin K W Chu1, See Ching Chan, Sheung Tat Fan, Kenneth S H Chok, Tan To Cheung, William W Sharr, Albert C Y Chan, Chung Mau Lo.   

Abstract

BACKGROUND: Hepatectomy is the main curative treatment for hepatocellular carcinoma (HCC), but postoperative long-term survival is poor. Preoperative radiological features of HCC displayed by computed tomography or magnetic resonance imaging could serve as additional prognostic factors. This study aimed to identify preoperative radiological features of HCC that may be of prognostic significance in hepatectomy.
METHODS: Ninety-two patients who underwent hepatectomy for HCC were included in this study. Preoperative radiological features including tumor number, size, location (peripheral, middle, central), portal vein invasion, hepatic vein invasion, and presence of pseudo-capsule were analyzed in relation to survival.
RESULTS: With a median follow-up period of 41.7 months, the 1-, 3- and 5-year overall survival rates were 85%, 65% and 58%, respectively. Univariate analysis showed that portal vein invasion and absence of pseudo-capsule were significant prognostic factors for overall survival, while all the examined radiological features were prognostic factors for disease-free survival. Multivariate analysis for overall survival found no significant factor. On multivariate analysis for disease-free survival, patients who had tumors with portal vein invasion had poorer survival with a hazard ratio of 2.26 (95% CI, 1.05-4.91; P=0.038) and patients with single nodular HCC or pseudo-capsulated HCC had better survival with a hazard ratio of 0.50 (95% CI, 0.27-0.94; P=0.032) and 0.38 (95% CI, 0.14-0.99; P=0.048), respectively.
CONCLUSIONS: Demonstrable pseudo-capsule of HCC and solitary HCC on imaging and absence of portal vein invasion are features associated with better disease-free survival after hepatectomy. These features may guide treatment planning for HCC.

Entities:  

Mesh:

Year:  2012        PMID: 23232632     DOI: 10.1016/s1499-3872(12)60232-x

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  5 in total

1.  Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

Authors:  Wing Chiu Dai; See Ching Chan; Kenneth S H Chok; Tan To Cheung; William W Sharr; Albert C Y Chan; Simon H Y Tsang; James Y Y Fung; Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

2.  Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?

Authors:  Apurva A Bonde; Elena K Korngold; Bryan R Foster; Antonio C Westphalen; David R Pettersson; Megan L Troxell; Jeffry P Simko; Fergus V Coakley
Journal:  Clin Imaging       Date:  2016-01-21       Impact factor: 1.605

3.  A (18)F-FDG PET/CT Screening Study of a Hepatocellular Carcinoma Patient with Diffuse (18)F-FDG Uptake into the Portal Vein and its Intrahepatic Branches.

Authors:  Reyhan Koroglu; Ismail Koksal; Fatma Gezer; Aysegul Kahraman; Ersoy Kekilli
Journal:  World J Nucl Med       Date:  2016 Jan-Apr

4.  Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma-a cost-effectiveness analysis.

Authors:  Kevin K W Chu; Albert C Y Chan; Ka Wing Ma; Wong Hoi She; Wing Chiu Dai; Kenneth S H Chok; Tan To Cheung; Chung Mau Lo
Journal:  Hepatobiliary Surg Nutr       Date:  2021-06       Impact factor: 7.293

5.  Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.

Authors:  Pulathis N Siriwardana; Tu Vinh Luong; Jennifer Watkins; Helen Turley; Mohamed Ghazaley; Kevin Gatter; Adrian L Harris; Daniel Hochhauser; Brian R Davidson
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.